Ms. Roxland concurrently served as the Special Advisor to the Commissioner of Health on
Stem Cell Research Ethics, where she spearheaded creation of state - wide rules on embryonic stem cell protocols, human - animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
Stem Cell Research Ethics, where she spearheaded creation of state - wide rules on embryonic stem cell protocols, human - animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
Cell Research Ethics, where she spearheaded creation of state - wide rules on embryonic stem cell protocols, human - animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological
Research Ethics, where she spearheaded creation of state - wide rules on embryonic
stem cell protocols, human - animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
stem cell protocols, human - animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
cell protocols, human - animal chimera
research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological
research, compensation of women who donate their oocytes to
stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samp
cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological
research,
informed consent processes, re-contact for return of
research results and incidental findings, and downstream uses of biological
research results and incidental findings, and downstream uses of biological samples.